Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vitazi.ai is a healthcare technology company specializing in artificial intelligence solutions for ophthalmology. The company's flagship product, Vitazi-DR, is an autonomous AI system designed to screen for diabetic retinopathy in primary care settings. By leveraging deep learning algorithms, Vitazi.ai aims to prevent vision loss through early detection and increased access to eye care. The platform integrates seamlessly into clinical workflows, providing immediate results without the need for an eye specialist's manual review. This approach addresses the significant gap in screening compliance among patients with diabetes by bringing diagnostic capabilities to the point of care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitazi.ai.